With biologic drugs becoming more prominent in the marketplace, protein engineers are now turning their attention to new indications, improved targeting, new formats and products that are truly differentiated relative to competitors. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics.

Conferences Include:

January 18-19

Recombinant Protein Therapeutics

January 19-20

Enhancing Antibody Binding and Specificity

January 19-20

Membrane Proteins

January 21-22

Emerging Technologies for Antibody Discovery and Engineering